FRANK KARBE - Chief Financial Officer at Cidara Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Chief Financial Officer
Issuer Symbol
CDTX on Nasdaq
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by FRANK KARBE since 05 Jan 2025

Holdings reported by FRANK KARBE for Cidara Therapeutics, Inc.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 50,562 $11,103,415 $219.60 10 Dec 2025 Direct
Employee Stock Option (right to buy) 115,000 24 Feb 2025 Direct Common Stock

Transactions reported by FRANK KARBE for Cidara Therapeutics, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.